The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Survival analysis and causes of mortality in patients with lupus nephritis
Open accessAbstract
BACKGROUND: This study aimed to define the causes and associated risks of death compared with the local general population in Chinese patients with lupus nephritis in the recent era. METHODS: The records of all lupus nephritis patients followed in a single centre during 1968-2008 were reviewed. The causes of death were identified, the survival curves constructed and the standardized mortality ratios (SMRs) of potential risk factors were calculated with reference to the local general population. RESULTS: Two hundred and thirty systemic lupus erythematosus patients with history of renal involvement (predominantly Class III/IV lupus nephritis with or without membranous features) were included. The follow-up was 4076.6 person-years (mean 17.7 ± 8.9 years). Twenty-four patients (10.4%) died, and 85% of the deaths occurred after 10 years of follow-up. The 5-, 10-, and 20-year survival rates were 98.6, 98.2 and 90.5%, respectively. The leading causes of death were infection (50.0%), cardiovascular disease (20.8%) and malignancy (12.5%). The renal survival rates at 5, 10 and 20 years were 99.5, 98.0 and 89.7%, respectively. The SMR in patients with renal involvement, end-stage renal disease (ESRD), malignancy or cardiovascular disease was 5.9, 26.1, 12.9 and 13.6, respectively. CONCLUSIONS: Lupus nephritis is associated with a 6-fold increase in mortality compared with the general population. Lupus patients who develop ESRD have a 26-fold excess in the risk of death, which is more than twice the risk associated with malignancy or cardiovascular disease in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
Weening, J. J., D’Agati, V. D., Schwartz, M. M., Seshan, S. V., Alpers, C. E., Appel, G. B., Balow, J. E., Bruijn, J. A., Cook, T., Ferrario, F., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000108969.21691.5d · Cited by 2,008
Manzi, S., Meilahn, E. N., Rairie, J. E., Conte, C. G., Medsger, T. A., Jansen-McWilliams, L., D'Agostino, R. B., & Kuller, L. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009122 · Cited by 1,834
(2022) · Singapore Medical Journal · doi:10.11622/smedj · Cited by 1,730
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B.-A., Davis, A., Lockshin, M. D., Sammaritano, L., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,427
Cervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., Gil, A., Lavilla, P., Mejía, J. C., Aydintug, A. O., Chwalinska-Sadowska, H., de Ramón, E., et al. (2003) · Medicine · doi:10.1097/01.md.0000091181.93122.55 · Cited by 1,377
Austin, H. A., Klippel, J. H., Balow, J. E., Le Riche, N. G. H., Steinberg, A. D., Plotz, P. H., & Decker, J. L. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603063141004 · Cited by 1,185
Mortality in systemic lupus erythematosus
Bernatsky, S., Boivin, J. ‐., Joseph, L., Manzi, S., Ginzler, E., Gladman, D. D., Urowitz, M., Fortin, P. R., Petri, M., Barr, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21955 · Cited by 1,181
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Appel, G. B., Contreras, G., Dooley, M. A., Ginzler, E. M., Isenberg, D., Jayne, D., Li, L.-S., Mysler, E., Sa[Combining Acute Accent]nchez-Guerrero, J., Solomons, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101028 · Cited by 1,118
Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis
Chan, T. M., Li, F. K., Tang, C. S. O., Wong, R. W. S., Fang, G. X., Ji, Y. L., Lau, C. S., Wong, A. K. M., Tong, M. K. L., Chan, K. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431604 · Cited by 954
Self-citationPremature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus
Asanuma, Y., Oeser, A., Shintani, A. K., Turner, E., Olsen, N., Fazio, S., Linton, M. F., Raggi, P., & Stein, C. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035611 · Cited by 892
Renal Insufficiency and Subsequent Death Resulting from Cardiovascular Disease in the United States
Muntner, P., He, J., Hamm, L., Loria, C., & Whelton, P. K. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133745 · Cited by 829
Renal Disease. Classification and Atlas of Glomerular Diseases.
(1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-5-801_2 · Cited by 672
Houssiau, F. A., Vasconcelos, C., D'Cruz, D., Sebastiani, G. D., de Ramon Garrido, E., Danieli, M. G., Abramovicz, D., Blockmans, D., Cauli, A., Direskeneli, H., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.102533 · Cited by 542
Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis
(2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440513 · Cited by 539
Korbet, S. M. (2010) · Cited by 519
Chan, T.-M., Tse, K.-C., Tang, C. S.-O., Mok, M.-Y., & Li, F.-K. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080686 · Cited by 479
Self-citationCervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., Gil, A., Lavilla, P., Aydintug, A. O., Jedryka-Góral, A., Ramón, E. D., Fernández-Nebro, A., et al. (1999) · Medicine · doi:10.1097/00005792-199905000-00003 · Cited by 430
Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.
Abu‐Shakra, M., Urowitz, M. B., Gladman, D. D., & Gough, J. (1995) · PubMed · Cited by 376
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
Isenberg, D., Appel, G. B., Contreras, G., Dooley, M. A., Ginzler, E. M., Jayne, D., Sánchez-Guerrero, J., Wofsy, D., Yu, X., & Solomons, N. (2010) · Rheumatology · doi:10.1093/rheumatology/kep346 · Cited by 356
An international cohort study of cancer in systemic lupus erythematosus
Bernatsky, S., Boivin, J. F., Joseph, L., Rajan, R., Zoma, A., Manzi, S., Ginzler, E., Urowitz, M., Gladman, D., Fortin, P. R., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21029 · Cited by 353
Long-Term Prognosis and Causes of Death in Systemic Lupus Erythematosus
Doria, A., Iaccarino, L., Ghirardello, A., Zampieri, S., Arienti, S., Sarzi-Puttini, P., Atzeni, F., Piccoli, A., & Todesco, S. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.11.034 · Cited by 350
Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus Erythematosus
UROWITZ, M. B., GLADMAN, D. D., TOM, B. D. M., IBAÑEZ, D., & FAREWELL, V. T. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080214 · Cited by 327
Mok, C. C., Tang, S. S. K., To, C. H., & Petri, M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21224 · Cited by 237
Nossent, J., Cikes, N., Kiss, E., Marchesoni, A., Nassonova, V., Mosca, M., Olesinska, M., Pokorny, G., Rozman, B., Schneider, M., et al. (2007) · Lupus · doi:10.1177/0961203307077987 · Cited by 223
Moss, K. E., Ioannou, Y., Sultan, S. M., Haq, I., & Isenberg, D. A. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.5.409 · Cited by 181
Mortality Risks Associated With Specific Clinical Manifestations of Systemic Lupus Erythematosus
Ward, M. M. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.12.1337 · Cited by 174
The very long-term prognosis and complications of lupus nephritis and its treatment
Bono, L. (1999) · QJM · doi:10.1093/qjmed/92.4.211 · Cited by 172
Effect of Age, Gender, and Diabetes on Excess Death in End-Stage Renal Failure
Villar, E., Remontet, L., Labeeuw, M., & Ecochard, R. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091048 · Cited by 168
An update on mortality in systemic lupus erythematosus.
Ippolito, A., & Petri, M. (2008) · PubMed · Cited by 131
Chronic Kidney Disease as a Predictor of Cardiovascular Disease (from the Framingham Heart Study)
Parikh, N. I., Hwang, S., Larson, M. G., Levy, D. A., & Fox, C. S. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.095 · Cited by 122
Age, sex, and race effects on mortality from systemic lupus erythematosus in the united states
Kaslow, R. A., & Masi, A. T. (1978) · Arthritis & Rheumatism · doi:10.1002/art.1780210412 · Cited by 114
Golbus, J., & McCune, W. J. (1994) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00232-5 · Cited by 106
Lupus nephritis. Classification, prognosis, immunopathogenesis, and treatment.
Golbus, J., & McCune, W. J. (1994) · PubMed · Cited by 96
High rate of death caused by systemic lupus erythematosus among U. S. residents of asian descent
Kaslow, R. A. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250409 · Cited by 86
Burgos, P. I., McGwin, G., Pons‐Estel, G., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.131482 · Cited by 76
Ward, M. M. (2004) · Arthritis Care & Research · doi:10.1002/art.20526 · Cited by 70
Incidence of cancer among female patients with systemic lupus erythematosus in Korea
Kang, K. Y., Kim, H. O., Yoon, H. S., Lee, J., Lee, W. C., Ko, H.-J., Ju, J. H., Cho, C., Kim, H., & Park, S. (2009) · Clinical Rheumatology · doi:10.1007/s10067-009-1332-7 · Cited by 69
The Clinical Course of End-Stage Renal Disease in Systemic Lupus Erythematosus
Jarrett, M. P. (1983) · Archives of Internal Medicine · doi:10.1001/archinte.1983.00350070073014 · Cited by 67
Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study.
Bellomio, Spindler, A. J., Lucero, E., et al. (2000) · PubMed · Cited by 56
Influence of socioeconomic status on cardiovascular diseases in Hong Kong.
Wong, S. L., & Donnan, S. P. B. (1992) · Journal of Epidemiology & Community Health · doi:10.1136/jech.46.2.148 · Cited by 40
Escárcega, R. O., García‐Carrasco, M., Jara, L. J., & Cervera, R. (2009) · Lupus · doi:10.1177/0961203308101435 · Cited by 18
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Self-citationTwo-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Furie, R., Rovin, B. H., Houssiau, F., Malvar, A., Teng, Y. K. O., Contreras, G., Amoura, Z., Yu, X., Mok, C.-C., Santiago, M. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001180 · Cited by 1,032
Almaani, S., Meara, A., & Rovin, B. H. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05780616 · Cited by 930
Fanouriakis, A., Kostopoulou, M., Cheema, K., Anders, H.-J., Aringer, M., Bajema, I., Boletis, J., Frangou, E., Houssiau, F. A., Hollis, J., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-216924 · Cited by 825
Tektonidou, M. G., Dasgupta, A., & Ward, M. M. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39594 · Cited by 582
Metadata
- Authors
- Yap, D. Y. H., Tang, C. S. O., Ma, M. K. M., Lam, M. F., & Chan, T. M.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-04-20
- Volume
- 27
- Issue
- 8
- Pages
- 3248-3254
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2128274902
- Cited by
- 319
- References
- 42
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.